Skip to
  1. Homepage
  2. Research and trials
  3. Research projects
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

20 Result(s)

Partnership : Academics = Academics, Industrials = Industrials, Financial investitors = Financial investitors

    • CANADA
    • Colombie-Britannique
    • VANCOUVER
    • FORGE - Finding of Rare Disease Genes in Canada
    • University of British Columbia
    • Faculty of Medicine
    • More details
    • CANADA
    • Ontario
    • OTTAWA, ONTARIO
    • FORGE - Finding of Rare Disease Genes in Canada
    • University of Ottawa
    • Faculty of Medicine -
    • More details
    • CANADA
    • Québec
    • MONTREAL
    • FORGE - Finding of Rare Disease Genes in Canada
    • Centre hospitalier universitaire Sainte-Justine
    • Pédiatrie
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • EVRY
    • NMD-CHIP: design, production and technical validation of candidate genes targeted chips (WP3)
    • Généthon
    • Généthon - Banque d'ADN et de cellules
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Clinical research on myofibrillary myopathies
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Centre de recherche de l'Institut du Cerveau et de la Moelle / Institut de myologie
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Synemin and neurofilaments associated with desmin function in neuromuscular diseases
    • Université Pierre et Marie Curie Paris 6 - UPMC
    • Génétique et Physiopathologie des muscles - UR 4
    • More details
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • NMD-CHIP: chip design, synthesis and technical validation for known genes involved in neuromuscular diseases (WP2)
    • CHU de Marseille - Hôpital de la Timone
    • Laboratoire de génétique moléculaire
    • More details
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Clinical research on myofibrillar myopathies
    • CHU de Marseille - Hôpital de la Timone
    • Laboratoire Angiogenèse, invasivité et micro-environnement tumoral
    • More details
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • The coassembly mechanism of muscle-specific intermediate filament proteins and the impact of human disease mutations on the formation of filaments and their integration into the cytoskeleton of myocytes ((FOR 1228: Molecular Pathogenesis of Myofibrillar Myopathies)
    • Deutsches Krebsforschungszentrum
    • Arbeitsgruppe 'Funktionelle Zellarchitektur' (B065)
    • More details
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Dissection of the pathogenesis of myofibrillar myopathies using a functional genomics approach in zebrafish (FOR 1228: Molecular Pathogenesis of Myofibrillar Myopathies)
    • Universitätsklinikum Ulm
    • Klinik für Innere Medizin II
    • More details
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Scanning for intensely fluorescent targets (SIFT): a new tool to study pathological protein aggregate formation in MFM and its reversal through pharmacologic intervention (FOR 1228: Molecular Pathogenesis of Myofibrillar Myopathies)
    • LMU Klinikum der Universität München
    • Labor für Molekulare Myologie
    • More details
    • GERMANY
    • Bayern
    • MÜNCHEN
    • BNE: BrainNet Europe II: European brain tissue bank - Network for clinical neuroscience and basic research (coordination)
    • Ludwig-Maximilians-Universität München
    • Zentrum für Neuropathologie und Prionforschung
    • More details
    • GERMANY
    • Bayern
    • WÜRZBURG
    • NMD-CHIP: Chip validation and quality assessment (WP5)
    • Universität Würzburg
    • Institut für Humangenetik
    • More details
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Implication of the new sarcomere protein calsarcin-2 (myozenin 1) in the pathogenesis of skeletal muscular diseases
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • Klinik für Innere Medizin III - Kardiologie und Angiologie
    • More details
    • ITALY
    • LOMBARDIA
    • SAN DONATO MILANESE
    • Validation of a neuromuscular individualized quality of life measure in Italy
    • IRCCS Policlinico San Donato
    • Clinica Neurologica - Centro per lo Studio delle Malattie Neuromuscolari
    • More details
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • McArm study: development of a motion controlled arm support
    • UMC St Radboud - Oost
    • Afdeling Revalidatie
    • More details
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • Myofibrillary myopathies: genetic characterization, immunohistochemical and immunobiological profiles, and differential gene expression
    • Hospital Universitari de Bellvitge
    • Unidad de Patología Neuromuscular
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Explaining and changing adverse illness perceptions in muscle disease by a cognitive behavioural therapy technique
    • Guy's Hospital
    • Health Psychology Section, Psychology Department, Institute of Psychiatry
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (coordination)
    • International Centre for Life
    • Institute of Genetic Medicine
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • NMD-CHIP: societal aspects of the development of targeted DNA-chips for high throughput diagnosis of neuromuscular disorders (WP7)
    • Newcastle University
    • Policy, Ethics and Life Sciences Research Centre
    • More details